A clinical team has spearheaded the use of CAR-T cell therapy for blood cancers. The researchers recently treated the first ...

A panel of experts discussed the transition of care between community and academic centers at the CURE Educated Patient ...

Dr. Cesar Rodriguez discussed treatment advancements for multiple myeloma during a CURE Educated Patient® Summit.

Pharmaceutical Administration Bureau has approved IASO Biotherapeutics’ new drug application (NDA) for equecabtagene ...

DelveInsight's "CARVYKTI Market Size, Forecast, and Market Insight Report" highlights the details around CARVYKTI, a ...

This is Allison’s personal multiple myeloma story, and others may be different. Allison is a paid spokesperson for GSK.

During a live event, Patrick Moore, MD, discussed the superior efficacy with ide-cel vs standard care in relapsed/refractory ...

While we've known that a healthy diet reduces the overall chance of getting cancer, there's now evidence that one eating plan ...

Action Month, created, according to the International Myeloma Foundation (IMF), “to draw attention to the disease and inspire ...

Triplet therapy with bortezomib, lenalidomide and dexamethasone — a regimen often referred to as VRd — is a current standard ...

Adam Perry shares the story of his journey discussing his diagnosis, treatment and the importance of early detection.